Health News Releases

  • Today May 18
June 04, 2019 09:12
New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from an ad-hoc analysis of the Phase 3 HELP Study™, designed to evaluate the onset of action for TAKHZYRO®
June 03, 2019 17:38
Takeda Makes First Private Sector Pledge for Global Fund Replenishment
Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new
May 29, 2019 18:19
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together Gubra’s established exp
May 28, 2019 14:15
New Agreement Between St. George’s University and NCUK - The University Consortium Provides International Students with a Unique Pathway to Medicine
St. George’s University, the international medical school on the Caribbean island of Grenada, has announced a new agreement with NCUK - The University Consortium (NCUK), based in Manchester, United K
May 27, 2019 10:53
Pioneering Project for Pharmaceutics - Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science
Nanopharmaceutics promises ground-breaking innovation in the development of medicines: · The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the U
St. George’s University students can now complete up to two years of the Pre-clinical and Medical De
May 27, 2019 09:00
St. George's University of Grenada, Northumbria University Expand Joint Medical Education Programme
St. George’s University and Northumbria University announced an expansion of their joint medical training programme that will allow students to complete up to two years of their pre-clinical and medic
May 24, 2019 09:30
Network of 1,500 Stroke-Ready Clinics across Europe
The Angels Initiative announced today at the European Stroke Organisation Conference (ESOC) 2019 in Milan that their three-year goal to create a network of 1,500 stroke-ready centres and hospitals acr
May 23, 2019 16:02
Takeda to Showcase Growing Pipeline and Diversified Portfolio of Oncology Products at Upcoming Scientific Congresses
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) today announced that the company will present data at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 31-Jun
May 22, 2019 11:31
ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring across 3 Countries
Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society’s
May 22, 2019 09:43
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD[1]
Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVCa) in patients with systemic sclerosis assoc
May 21, 2019 10:17
New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery
Masimo (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and con
May 20, 2019 11:20
Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought
ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thora
May 20, 2019 10:19
New Exploratory Data from VARSITY, First Head-to-Head Ulcerative Colitis Biologic Study Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week®
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced further results from the Phase 3b head-to-head VARSITY study, which demonstrated that the gut-selective biologic ve
May 20, 2019 09:42
WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology
The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers
May 17, 2019 15:32
Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190513005951/en/ FY2018
May 17, 2019 13:44
German Diabetes Clinic Increases Diabetic Retinopathy Screenings From Zero to Thousands After Implementing Eyenuk’s EyeArt AI Eye Screening System
Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today results of its expansion int
May 17, 2019 13:27
Takeda and London School of Hygiene & Tropical Medicine Establish “Takeda Chair in Global Child Health”
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) and the London School of Hygiene & Tropical Medicine (LSHTM) will announce today at the evening reception, hosted by the Embassy
May 17, 2019 09:30
EcoTT Set on Taking over the Global Market with Hanji Safety Mask and Konjac with Dark Temptation, a Snack for Weight Control
EcoTT Co., Ltd., a Korean general trading company, announced the plan to launch its new products including Novrect Hanji Safety Mask and Konjac with Dark Temptation, a snack for weight control, on Ama
May 17, 2019 08:52
SpinalCyte Launches Initiative to Highlight Advances in Fibroblast Technology
SpinalCyte, LLC, a clinical stage regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced a new comprehensive resource to raise awar
May 16, 2019 19:49
Trial results of Pradaxa® vs ASA in ESUS published in NEJM
Boehringer Ingelheim today announced full results from the RE-SPECT ESUS® trial, a Phase III randomised, double-blind study investigating the efficacy and safety of Pradaxa® (dabigatran etexilate) ver
May 16, 2019 10:45
Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent
Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biode
May 16, 2019 08:51
LifeArc and GVK BIO Celebrate a Decade of Partnership, Transforming Research into Life-Saving Medicines
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce the 10th anniversary of a successful p
May 15, 2019 17:15
Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will feature 7 presentations, including one oral presentation, at the upcoming European Congress of Endocri
May 15, 2019 11:55
SpeeDx Receives Clearance for PlexPCR Respiratory Virus Test
SpeeDx Pty. Ltd. today announced the clearance of the PlexPCR® RespiVirus* test from the Australian Therapeutic Goods Administration (TGA). The test utilises market-leading PlexPCR® technology to dete
May 14, 2019 10:15
Masimo and Mindray Announce Expanded Partnership
Masimo (NASDAQ: MASI) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE: 300760) announced today that they have entered into a purchase and license agreement, under which Mindray will offer
25 per page50 per page75 per page100 per page